Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
EBITDA as a percentage of revenue
Latest
-144.82%
↑ 90% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-1476.31%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -144.82% | +34.1% |
| 2024 | -219.70% | +18.3% |
| 2023 | -268.76% | -81.3% |
| 2022 | -148.22% | +88.1% |
| 2021 | -1240.71% | +60.7% |
| 2020 | -3157.57% | -30.1% |
| 2019 | -2427.33% | +8.9% |
| 2018 | -2663.98% | -27.8% |
| 2017 | -2084.82% | +13.4% |
| 2016 | -2407.19% | - |